En los lactantes, la ERGE puede causar vómitos y malhumor después de comer. En niños mayores y adolescentes, la ERGE puede generar acidez y malestar en el estómago y el pecho. del Rosario, MD. Fecha de revisión: enero de Artículo anterior | Artículo siguiente · Vol. clínica sobre el manejo del paciente con enfermedad por reflujo gastroesofágico (ERGE) Información del artículo. Revisión sobre enfermedad por reflujo gastroesofágico (ERGE) Available in: ?id= · How to cite · Complete.

Author: Zologul Yojas
Country: Guadeloupe
Language: English (Spanish)
Genre: Medical
Published (Last): 6 May 2011
Pages: 287
PDF File Size: 13.41 Mb
ePub File Size: 2.84 Mb
ISBN: 764-5-12670-243-5
Downloads: 68454
Price: Free* [*Free Regsitration Required]
Uploader: Bami

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.

Cochrane Database Syst Rev: A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Scand J Gastroenterol, 33pp.

Domperidone, metoclopramide, and placebo. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal.

The usefulness of a structured questionnaire in the assesment of symptomatic gastroesophageal reflux disease. CMAJ,pp.


Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: Adverse effects of long-term proton pump inhibitor therapy. Am J Managed Care, 5pp. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.

Gastro-oesophageal reflux symptoms -Clinical findings revisionn effect of ranitidine treatment.

There was a problem providing the content you requested

The relation of gastroesophageal reflux disease and its revvision to adenocarcinomas of the esophagus and gastric cardia. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease GERD who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study. Aliment Pharmacol Ther, 15pp.

Comparison of laparoscopic and open Nissen fundoplication 2 years after operation. Gastroenterol Clin North Am ; Cochrane Database Syst Rev ; Eur J Gen Pract, 5 revosion, pp. Ontario Guideline for peptic ulcer disease and gastroesophageal reflux.

Gut, 36pp. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Asthma articuol gastroesophageal reflux. Handbook and atlas of endoscopy. Efficacy and tolerability of 20 mg pantoprazole versus mg ranitidine in patients with mild reflux-oesophagitis: Evaluation of primary repair in consecutive patients.


Gastrointest Endosc ; Si continua navegando, consideramos que acepta su uso.

Lancet,pp. Bavishi C, Dupont HL. Br J Clin Pharmacol ; Efficacy and cost effectiveness of lansoprazole versus omeprazole in maintenance treatment of symptomatic gastroeso-phageal reflux disease. Pantoprazole versus omeprazole in the treatment of reflux reviision.

A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans.

Revisión sobre enfermedad por reflujo gastroesofágico – Artículos – IntraMed

Heartburn treatment in primary care: Helicobacter pylori infection and gastro-oesophageal reflux disease: Comparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo in the treatment of gastrooesophageal reflux disease. Effective maintenance treatment of reflux eso-phagitis with low-dose lansoprazole. Impedance baseline and reflux perception in revisiom and non-responder non-erosive reflux disease patients.